AiMIFY (1.x)

by Subtle Medical  · Based in United States → — Deep Learning boosts healthcare. Faster, Safer, Smarter.
Neurology Neurosurgery Radiology

Regulatory Status Disclosed

Overview

AiMIFY (1.x) is an AI-powered software developed by Subtle Medical and sold by Bracco, designed to significantly enhance Magnetic Resonance Imaging (MRI) of the brain. Contrary to a physician directory tool, AiMIFY focuses on improving the visualization of small and poorly enhanced lesions by selectively amplifying contrast enhancement in brain MRI scans. This technology integrates seamlessly into existing radiology workflows, sitting between the MRI scanner and the Picture Archiving and Communication System (PACS), and is compatible with any brand of MRI scanner. AiMIFY aims to provide radiologists and neuroradiologists with clearer, more detailed images, thereby enhancing diagnostic confidence.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-driven brain MRI enhancement
  • Amplifies contrast enhancement up to 2x for GBCAs
  • Improves visualization of small and poorly enhanced lesions
  • Increases contrast-to-noise ratio (CNR)
  • Increases contrast enhancement (CEP)
  • Increases lesion-to-brain ratio (LBR)
  • Vendor-neutral software solution
  • Seamless integration into existing radiology workflow
  • Compatible with all MRI scanner brands and PACS

Use Cases

  • Enhancing diagnostic confidence in brain MRI reads
  • Improving detection of small and poorly enhanced brain lesions
  • Optimizing image quality for contrast-enhanced brain MRI
  • Streamlining radiology workflows by providing clearer images

What Physicians Need to Know

Brain MRI/CT Analysis
SubtleMR and SubtlePET enhance image quality for faster MRI and PET scans, which are crucial for neuroimaging analysis.
Neurodegenerative Disease Screening
Improved image quality from SubtleMR and SubtlePET can aid in the detection and monitoring of neurodegenerative diseases by providing clearer diagnostic images.
Physician Tip

Subtle Medical's AI tools focus on improving image quality and accelerating scan times for MRI and PET. This can be particularly beneficial in neurology for patients who have difficulty remaining still for long periods, or in busy imaging centers where throughput is critical. While not directly a diagnostic AI, the enhanced image quality can improve the accuracy and confidence of physician interpretations for various neurological conditions.

Subtle Medical's solutions are designed to integrate seamlessly into existing radiology workflows and PACS systems, operating in the background to process images without requiring changes to scanner hardware or radiologist workflow.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based or on-premise.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-08-21K240290 510(k)AiMIFY (1.x)

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AiMIFY (1.x)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AiMIFY (1.x).

Loading videos...

View all on YouTube

Frequently Asked Questions

AiMIFY (1.x) is an AI-powered image processing software developed by Subtle Medical in collaboration with Bracco Imaging. It enhances contrast in brain MRI scans, aiming to improve the visibility of small and poorly enhanced lesions, which can be critical for early detection and assessment of neurological conditions. The software can amplify contrast enhancement up to twice the level typically achieved with a standard dose of gadolinium-based contrast agents (GBCAs).
Yes, AiMIFY (1.x) has received FDA 510(k) clearance as a Class II Software as a Medical Device (SaMD) in August 2024. It also obtained the CE Mark under the European Medical Device Regulation (MDR) in June 2025, confirming its compliance with EU safety, health, and environmental protection standards. Subtle Medical maintains a Quality Management System (QMS) and an Artificial Intelligence Management System (AIMS) to ensure compliance with applicable regulations and standards.
AiMIFY-enhanced images should not be used alone for patient diagnosis; the standard post-contrast image must always be reviewed first. The software has been trained and tested on specific T1-weighted imaging sequences for pre and post-contrast brain scans with GBCAs, and using it outside these parameters may lead to prolonged processing times or unreasonable results. Additionally, AiMIFY-enhanced images may show increased vessel conspicuity or false lesions, requiring careful comparison with standard images.
While AiMIFY focuses on contrast enhancement for brain MRI, other AI-powered solutions exist for MRI image improvement. Subtle Medical also offers SubtleHD for MR, which provides denoising and sharpening for ultra-clear MRI images, and SubtleSYNTH, which generates MR imaging contrasts. The main alternative to Subtle Medical's offerings for MRI acceleration is AIRS Medical SwiftMR, which also provides vendor-neutral MRI acceleration software. Additionally, scanner manufacturers like GE, Siemens, Philips, and Canon offer their own deep learning reconstruction technologies.
Subtle Medical does not publicly disclose pricing for AiMIFY (1.x); all tiers are custom-quoted. The software is typically purchased by imaging departments rather than individual radiologists.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Subtle Medical

SubtleHD (1.x)
Subtle Medical
Radiology & Imaging AI
SubtleHD(MR)™ is a cutting-edge AI software that dramatically improves image quality and enables up to 80% faster scans on any existing MRI machine, enhancing diagnostic confidence and operational efficiency.
SubtleHD-CT
Subtle Medical, Inc.
Radiology & Imaging AI
Subtle Medical's SubtleHD-CT is an AI software designed to enhance the quality and resolution of CT scans, reducing noise and improving image clarity. [7]
SubtleHD-CT (1.x)
Subtle Medical, Inc.
Radiology & Imaging AI
SubtleHD-CT (1.x) is an AI-powered software from Subtle Medical that enhances CT image quality, enabling faster scans and improved diagnostic confidence.
SubtleHD-PET (1.x)
Subtle Medical, Inc.
Radiology & Imaging AI
SubtleHD-PET uses AI to enhance PET image quality, enabling faster scans and lower radiotracer doses while maintaining diagnostic integrity.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19

Investors who backed AiMIFY (1.x)

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.